Income Statement Precise Biometrics AB Deutsche Boerse AG

Stocks

PBC

SE0018013849

Electronic Equipment & Parts

Delayed Deutsche Boerse AG Other stock markets 02:16:42 2026-07-07 EDT			5-day change	1st Jan Change
0.1554 ^EUR	+0.26%		-2.75%	-22.69%

10:36am	Precise Biometrics: 1.86 billion replacement warrants to be issued	FW
07-03	Calendar Monday, July 6 - Friday, July 10	FW

c422800eaea.6kC3ZTSjVx_4uWu062no9BL21DnNut1sRdUuifPLTkQ.gzLRD030ZG-h4wzd3xuLlUPOk1SO9oJeP4BM85mhPze6cvk2WPYZSM3IUw

Published financial data: PRECISE BIOMETRICS AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	83.32M	91.02M	75.07M	86.85M	77.81M
Total Revenues	83.32M	91.02M	75.07M	86.85M	77.81M
Cost of Goods Sold, Total	19.78M	25.98M	27.25M	23.79M	21.15M
Gross Profit	63.54M	65.04M	47.82M	63.07M	56.67M
Selling General & Admin Expenses, Total	47.09M	52.41M	41.57M	46.77M	46.56M
R&D Expenses	28.16M	34.9M	32.1M	26.97M	27.25M
Other Operating Expenses	-212K	-2.26M	606K	-1.26M	2.92M
Other Operating Expenses, Total	75.04M	85.05M	74.28M	72.48M	76.73M
Operating Income	-11.5M	-20.02M	-26.46M	-9.42M	-20.06M
Interest Expense, Total	-223K	-3.41M	-1M	-386K	-613K
Interest And Investment Income	-	-	538K	892K	784K
Net Interest Expenses	-223K	-3.41M	-462K	506K	171K
Currency Exchange Gains (Loss)	947K	-40K	171K	123K	-384K
Other Non Operating Income (Expenses)	-	-	0	2K	1K
EBT, Excl. Unusual Items	-10.77M	-23.47M	-26.75M	-8.78M	-20.27M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-2.58M	-	-	-	-
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	-13.35M	-23.47M	-26.75M	-8.78M	-20.27M
Income Tax Expense	97K	-1.24M	-346K	-351K	-347K
Earnings From Continuing Operations	-13.45M	-22.23M	-26.4M	-8.43M	-19.92M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-13.45M	-22.23M	-26.4M	-8.43M	-19.92M
Net Income - (IS)	-13.45M	-22.23M	-26.4M	-8.43M	-19.92M
Net Income to Common Incl Extra Items	-13.45M	-22.23M	-26.4M	-8.43M	-19.92M
Net Income to Common Excl. Extra Items	-13.45M	-22.23M	-26.4M	-8.43M	-19.92M
Per Share Items
Net EPS - Basic	-0.37	-0.54	-0.4	-0.11	-0.26
Basic EPS - Continuing Operations	-0.37	-0.54	-0.4	-0.11	-0.26
Basic Weighted Average Shares Outstanding	36.22M	41.3M	65.57M	78.46M	77.38M
Net EPS - Diluted	-0.4	-0.54	-0.4	-0.11	-0.26
Diluted EPS - Continuing Operations	-0.4	-0.54	-0.4	-0.11	-0.26
Diluted Weighted Average Shares Outstanding	36.22M	41.3M	65.57M	78.46M	77.38M
Normalized Basic EPS	-0.19	-0.36	-0.25	-0.07	-0.16
Normalized Diluted EPS	-0.19	-0.36	-0.25	-0.07	-0.16
Supplemental Items
EBITDA	-9.31M	-15.76M	-22.53M	-5.72M	-16.59M
EBITA	-10.53M	-17.56M	-24.03M	-6.98M	-17.66M
EBIT	-11.5M	-20.02M	-26.46M	-9.42M	-20.06M
EBITDAR	-7.1M	-13.4M	-19.68M	-2.69M	-13.6M
Effective Tax Rate - (Ratio)	-0.73	5.28	1.29	4	1.71
Total Current Taxes	128K	12K	17K	13K	14K
Total Deferred Taxes	-31K	-1.25M	-363K	-364K	-361K
Normalized Net Income	-6.73M	-14.67M	-16.72M	-5.49M	-12.67M
Interest on Long-Term Debt	223K	256K	218K	331K	479K
Supplemental Operating Expense Items
Selling and Marketing Expenses	31.65M	34.8M	27.42M	32.98M	32.44M
General and Administrative Expenses	15.44M	17.61M	14.15M	13.79M	14.12M
Research And Development Expense From Footnotes	40.31M	49.81M	50.48M	43.43M	41.48M
Net Rental Expense, Total	2.21M	2.36M	2.85M	3.02M	2.99M
Imputed Operating Lease Interest Expense	547K	3.19M	834K	436K	790K
Imputed Operating Lease Depreciation	1.66M	-835K	2.02M	2.59M	2.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	64.1M	46.4M	47.53M	37.7M	18.41M
Total Cash And Short Term Investments	64.1M	46.4M	47.53M	37.7M	18.41M
Accounts Receivable, Total	24.03M	11.48M	19.17M	23.81M	18.75M
Other Receivables	1.92M	3.64M	3.5M	3.12M	2.36M
Total Receivables	25.95M	15.12M	22.67M	26.94M	21.11M
Inventory	548K	311K	359K	242K	277K
Prepaid Expenses	3.51M	3.4M	2.9M	2.8M	2.7M
Other Current Assets, Total	-	-	-1K	-	-
Total Current Assets	94.11M	65.23M	73.47M	67.69M	42.49M
Gross Property Plant And Equipment	13.45M	12.85M	11.25M	16.79M	18.58M
Accumulated Depreciation	-1.99M	-3.76M	-4.8M	-6.15M	-6.63M
Net Property Plant And Equipment	11.47M	9.09M	6.45M	10.64M	11.95M
Goodwill	84.84M	84.84M	84.84M	84.84M	84.84M
Other Intangibles, Total	26.72M	24.26M	21.83M	19.4M	17M
Deferred Tax Assets Long-Term	-	-	-	-	-
Deferred Charges Long-Term	23.93M	29.8M	26.08M	20.51M	17.84M
Other Long-Term Assets, Total	-	-	-1K	-1K	-
Total Assets	241M	213M	213M	203M	174M
Liabilities
Accounts Payable, Total	10.08M	5.95M	2.72M	2.3M	2.42M
Accrued Expenses, Total	26.55M	5.08M	8.45M	9.66M	8.71M
Current Portion of Leases	1.67M	11.74M	8.47M	8.24M	7.43M
Unearned Revenue Current, Total	-	17.07M	13.94M	13.24M	10.15M
Other Current Liabilities	34.24M	1.73M	2.31M	2.19M	2.26M
Total Current Liabilities	72.54M	41.57M	35.89M	35.62M	30.96M
Long-Term Leases	5.93M	20.99M	13.46M	12.64M	8.87M
Deferred Tax Liability Non Current	5.62M	4.36M	4M	3.64M	3.28M
Other Non Current Liabilities	28.92M	-	-1K	-	-1K
Total Liabilities	113M	66.92M	53.35M	51.9M	43.1M
Common Stock, Total	11.88M	14.25M	23.54M	23.54M	23.54M
Additional Paid In Capital	849M	888M	918M	918M	918M
Retained Earnings	-737M	-760M	-786M	-795M	-815M
Comprehensive Income and Other	4.27M	4.53M	4.41M	4.68M	4.46M
Total Common Equity	128M	146M	159M	151M	131M
Total Equity	128M	146M	159M	151M	131M
Total Liabilities And Equity	241M	213M	213M	203M	174M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	39.6M	46.43M	77.38M	77.38M	77.38M
ECS Total Common Shares Outstanding	39.6M	46.43M	77.38M	77.38M	77.38M
Book Value / Share	3.23	3.15	2.06	1.95	1.69
Tangible Book Value	16.5M	37.21M	52.65M	46.93M	29.18M
Tangible Book Value Per Share	0.42	0.8	0.68	0.61	0.38
Total Debt	7.6M	32.72M	21.93M	20.88M	16.3M
Net Debt	-56.51M	-13.68M	-25.61M	-16.82M	-2.11M
Debt Equivalent Oper. Leases	17.66M	18.85M	22.8M	24.18M	23.95M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Finished Goods, Total	548K	311K	359K	242K	277K
Machinery, Total	6.18M	7.12M	7.24M	7.72M	8.27M
Full Time Employees	31	30	31	35	36
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	1.44M	1.35M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-13.45M	-22.23M	-26.4M	-8.43M	-19.92M
Depreciation & Amortization - CF	2.73M	3.75M	3.89M	3.82M	3.45M
Amortization of Goodwill and Intangible Assets - (CF)	964K	2.46M	2.43M	2.43M	2.4M
Depreciation & Amortization, Total	3.69M	6.21M	6.32M	6.25M	5.85M
Amortization of Deferred Charges, Total - (CF)	12.28M	15.03M	18.45M	16.54M	14.31M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Other Operating Activities, Total	-1.44M	1.84M	397K	-239K	-375K
Change In Accounts Receivable	-6.28M	11.08M	-7.08M	-4.11M	5.87M
Change In Inventories	504K	237K	-48K	117K	-35K
Change in Other Net Operating Assets	3.2M	-8.23M	-2.39M	-71K	-3.78M
Cash from Operations	-1.49M	3.93M	-10.76M	10.06M	1.92M
Capital Expenditure	-2.82M	-284K	-1.22M	-370K	-1.26M
Cash Acquisitions	-10.68M	-38.27M	-10M	-6.17M	-6.02M
Sale (Purchase) of Intangible assets	-16.76M	-21.46M	-14.1M	-10.97M	-11.65M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-30.26M	-60.01M	-25.32M	-17.5M	-18.93M
Long-Term Debt Repaid, Total	-1.28M	-1.9M	-2.26M	-2.54M	-2.32M
Total Debt Repaid	-1.28M	-1.9M	-2.26M	-2.54M	-2.32M
Issuance of Common Stock	23M	44.32M	49.52M	-	-
Repurchase of Common Stock	-	-326K	-	-3K	-
Other Financing Activities, Total	-2.18M	-3.78M	-9.98M	-	407K
Cash from Financing	19.54M	38.31M	37.29M	-2.54M	-1.91M
Foreign Exchange Rate Adjustments	52K	67K	-83K	164K	-372K
Miscellaneous Cash Flow Adjustments	-	-1K	1K	1K	3K
Net Change in Cash	-12.16M	-17.7M	1.13M	-9.83M	-19.29M
Supplemental Items
Cash Interest Paid	223K	256K	218K	331K	479K
Cash Income Tax Paid (Refund)	141K	21K	9K	22K	-5K
Levered Free Cash Flow	17.93M	-45M	-17.22M	1.24M	-3.62M
Unlevered Free Cash Flow	18.07M	-42.87M	-16.6M	1.49M	-3.24M
Change In Net Working Capital	-28.86M	29.86M	9.52M	4.09M	-2.05M
Net Debt Issued / Repaid	-1.28M	-1.9M	-2.26M	-2.54M	-2.32M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-3.65	-5.51	-7.77	-2.83	-6.65
Return on Total Capital	-5.6	-7.95	-9.18	-3.33	-7.85
Return On Equity %	-11.11	-16.21	-17.28	-5.43	-14.12
Return on Common Equity	-11.11	-16.21	-17.28	-5.43	-14.12
Margin Analysis
Gross Profit Margin %	76.26	71.45	63.71	72.61	72.82
SG&A Margin	56.52	57.58	55.38	53.85	59.83
EBITDA Margin %	-11.17	-17.31	-30.02	-6.58	-21.32
EBITA Margin %	-12.64	-19.29	-32.01	-8.04	-22.7
EBIT Margin %	-13.8	-21.99	-35.24	-10.84	-25.78
Income From Continuing Operations Margin %	-16.14	-24.42	-35.17	-9.71	-25.6
Net Income Margin %	-16.14	-24.42	-35.17	-9.71	-25.6
Net Avail. For Common Margin %	-16.14	-24.42	-35.17	-9.71	-25.6
Normalized Net Income Margin	-8.08	-16.12	-22.27	-6.32	-16.28
Levered Free Cash Flow Margin	21.52	-49.45	-22.94	1.43	-4.66
Unlevered Free Cash Flow Margin	21.69	-47.1	-22.11	1.71	-4.16
Asset Turnover
Asset Turnover	0.42	0.4	0.35	0.42	0.41
Fixed Assets Turnover	8.17	8.86	9.66	10.17	6.89
Receivables Turnover (Average Receivables)	4.51	5.13	4.9	4.04	3.66
Inventory Turnover (Average Inventory)	24.72	60.49	81.33	79.15	81.49
Short Term Liquidity
Current Ratio	1.3	1.57	2.05	1.9	1.37
Quick Ratio	1.24	1.48	1.96	1.81	1.28
Operating Cash Flow to Current Liabilities	-0.02	0.09	-0.3	0.28	0.06
Days Sales Outstanding (Average Receivables)	80.96	71.19	74.52	90.57	99.83
Days Outstanding Inventory (Average Inventory)	14.77	6.03	4.49	4.62	4.48
Average Days Payable Outstanding	149.18	113.61	58	38.84	40.64
Cash Conversion Cycle (Average Days)	-53.45	-36.39	21.01	56.36	63.67
Long Term Solvency
Total Debt/Equity	5.93	22.37	13.76	13.81	12.44
Total Debt / Total Capital	5.6	18.28	12.1	12.14	11.06
LT Debt/Equity	4.63	14.34	8.45	8.36	6.77
Long-Term Debt / Total Capital	4.37	11.72	7.43	7.35	6.02
Total Liabilities / Total Assets	46.88	31.39	25.08	25.56	24.76
EBIT / Interest Expense	-51.55	-5.86	-26.46	-24.39	-32.72
EBITDA / Interest Expense	-35	-4.04	-20.14	-8.2	-23.18
(EBITDA - Capex) / Interest Expense	-47.66	-4.13	-21.36	-9.16	-25.24
Total Debt / EBITDA	-0.97	-2.37	-1.09	-6.6	-1.15
Net Debt / EBITDA	7.24	0.99	1.27	5.31	0.15
Total Debt / (EBITDA - Capex)	-0.71	-2.32	-1.03	-5.91	-1.05
Net Debt / (EBITDA - Capex)	5.32	0.97	1.2	4.76	0.14
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-9.78	9.24	-17.52	15.7	-10.41
Gross Profit, 1 Yr. Growth %	-18.29	2.35	-26.47	31.87	-10.14
EBITDA, 1 Yr. Growth %	112.93	69.28	42.33	-74.63	190.27
EBITA, 1 Yr. Growth %	111.57	66.69	36.89	-70.94	152.86
EBIT, 1 Yr. Growth %	98.48	74.11	32.18	-64.42	113.05
Earnings From Cont. Operations, 1 Yr. Growth %	10.54	65.33	18.77	-68.06	136.26
Net Income, 1 Yr. Growth %	9.86	65.33	18.77	-68.06	136.26
Normalized Net Income, 1 Yr. Growth %	68.05	117.87	13.98	-67.16	130.77
Diluted EPS Before Extra, 1 Yr. Growth %	18.46	44.99	-25.18	-72.68	136.36
Accounts Receivable, 1 Yr. Growth %	85.78	-52.23	67.04	24.2	-21.25
Inventory, 1 Yr. Growth %	-47.91	-43.25	15.43	-32.59	14.46
Net Property, Plant and Equip., 1 Yr. Growth %	28.51	-20.72	-29.06	65.01	12.28
Total Assets, 1 Yr. Growth %	57.6	-11.55	-0.26	-4.51	-14.25
Tangible Book Value, 1 Yr. Growth %	-80.82	125.49	41.51	-10.87	-37.82
Common Equity, 1 Yr. Growth %	12.28	14.25	8.9	-5.12	-13.33
Cash From Operations, 1 Yr. Growth %	-106.85	-363.3	-373.72	-193.45	-80.92
Capital Expenditures, 1 Yr. Growth %	36.91	-89.94	327.82	-69.55	240.81
Levered Free Cash Flow, 1 Yr. Growth %	158.22	-350.99	-61.8	-107.22	-391.23
Unlevered Free Cash Flow, 1 Yr. Growth %	157.88	-337.25	-61.35	-108.95	-318.15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.8	-0.72	-5.08	-2.32	1.81
Gross Profit, 2 Yr. CAGR %	-10.57	-8.55	-13.25	-1.53	8.86
EBITDA, 2 Yr. CAGR %	122.14	89.85	55.6	-39.91	-14.19
EBITA, 2 Yr. CAGR %	168.22	87.8	51.06	-36.93	-14.28
EBIT, 2 Yr. CAGR %	320.23	85.9	51.71	-31.42	-12.93
Earnings From Cont. Operations, 2 Yr. CAGR %	262.9	35.19	40.13	-38.41	-13.13
Net Income, 2 Yr. CAGR %	375.78	34.77	40.13	-38.41	-13.13
Normalized Net Income, 2 Yr. CAGR %	964.84	91.35	57.58	-38.82	-12.95
Diluted EPS Before Extra, 2 Yr. CAGR %	276.02	26.25	4.16	-54.79	-19.65
Accounts Receivable, 2 Yr. CAGR %	-9.41	-5.79	-10.67	44.04	-1.1
Inventory, 2 Yr. CAGR %	-	-45.63	-19.06	-11.79	-12.16
Net Property, Plant and Equip., 2 Yr. CAGR %	146.63	0.94	-25.01	8.19	36.12
Total Assets, 2 Yr. CAGR %	23.33	18.07	-6.07	-2.41	-9.51
Tangible Book Value, 2 Yr. CAGR %	-58.89	-34.24	78.63	12.3	-25.56
Common Equity, 2 Yr. CAGR %	0.62	13.26	11.54	1.65	-9.32
Cash From Operations, 2 Yr. CAGR %	76.92	-57.53	168.46	59.93	-57.77
Capital Expenditures, 2 Yr. CAGR %	201.77	-62.89	-34.4	14.14	1.88
Levered Free Cash Flow, 2 Yr. CAGR %	99.22	154.58	-1.99	-83.39	-54.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	104.85	147.35	-4.16	-81.4	-55.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.19	-0.33	-6.67	1.39	-5.09
Gross Profit, 3 Yr. CAGR %	3.3	-6.46	-14.96	-0.25	-4.49
EBITDA, 3 Yr. CAGR %	-20.74	102.9	72.75	-15	1.58
EBITA, 3 Yr. CAGR %	-18.06	128.89	69.01	-12.8	0.2
EBIT, 3 Yr. CAGR %	-16.79	213.28	65.92	-6.44	0.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-15.38	179.24	29.48	-14.4	-3.58
Net Income, 3 Yr. CAGR %	-13.05	234.49	29.21	-14.4	-3.58
Normalized Net Income, 3 Yr. CAGR %	-19.39	527.47	61	-6.57	-4.77
Diluted EPS Before Extra, 3 Yr. CAGR %	-13.4	166.95	6.04	-33.33	-21.54
Accounts Receivable, 3 Yr. CAGR %	6.9	-26.81	14.02	-0.3	17.78
Inventory, 3 Yr. CAGR %	-	-	-30.12	-23.85	-3.79
Net Property, Plant and Equip., 3 Yr. CAGR %	132.02	68.95	-10.26	-2.46	9.54
Total Assets, 3 Yr. CAGR %	14.93	10.4	11.61	-5.56	-6.53
Tangible Book Value, 3 Yr. CAGR %	-44.37	-27.5	-15.1	41.68	-7.78
Common Equity, 3 Yr. CAGR %	0.68	4.98	11.79	5.69	-3.61
Cash From Operations, 3 Yr. CAGR %	-61.45	101.99	-20.96	88.85	-21.26
Capital Expenditures, 3 Yr. CAGR %	89.32	-2.88	-16.16	-49.2	64.36
Levered Free Cash Flow, 3 Yr. CAGR %	-17.03	115.16	35.36	-58.91	-56.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	-16.81	115.13	33.3	-56.52	-57.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0	8.32	2.1	-1.13	-3.37
Gross Profit, 5 Yr. CAGR %	-4.88	2.69	-3.67	-4.52	-6.13
EBITDA, 5 Yr. CAGR %	-18.99	4.91	3.81	24.83	30.58
EBITA, 5 Yr. CAGR %	-16.15	5.89	4.65	36.68	28.82
EBIT, 5 Yr. CAGR %	-14.67	7.51	5.8	70.63	28.2
Earnings From Cont. Operations, 5 Yr. CAGR %	-19.01	-0.41	3.54	52.54	10.37
Net Income, 5 Yr. CAGR %	-15.49	4.98	5.24	70	10.24
Normalized Net Income, 5 Yr. CAGR %	-15.76	8.51	5.4	147.28	25.89
Diluted EPS Before Extra, 5 Yr. CAGR %	-18.32	-3.1	-8.15	31.2	-5.09
Accounts Receivable, 5 Yr. CAGR %	5.44	-2.62	-0.51	-4.05	7.71
Inventory, 5 Yr. CAGR %	-24.2	-	-	-	-23.42
Net Property, Plant and Equip., 5 Yr. CAGR %	54.92	56.9	47.68	41.36	6.01
Total Assets, 5 Yr. CAGR %	4.21	2.37	6.02	5.08	2.63
Tangible Book Value, 5 Yr. CAGR %	-36.75	-20.25	-11.29	-13.63	-19.45
Common Equity, 5 Yr. CAGR %	-4.71	0.07	4.89	3.63	2.81
Cash From Operations, 5 Yr. CAGR %	-47.56	-29.63	-16.21	83.98	-38.49
Capital Expenditures, 5 Yr. CAGR %	45.9	-17.09	23.91	3.6	-9.37
Levered Free Cash Flow, 5 Yr. CAGR %	-10.93	29.42	-11.31	-22.73	-12.2
Unlevered Free Cash Flow, 5 Yr. CAGR %	-10.8	28.16	-11.96	-19.17	-14.29